Ischemic heart disease Board decisions

The Board granted service connection for right upper extremity (RUE) cervical radiculopathy and remanded the claims for hypertension, heart condition, prostate condition, and G6PD deficiency.

The Veteran was granted a total disability rating based upon individual unemployability due to service-connected coronary artery disease alone and special monthly compensation under 38 U.S.C. § 1114(s) prior to August 31, 2015.

The Board granted service connection for hypertensive heart disease as secondary to hypertension, but remanded the claims for skin condition, heart condition other than hypertensive heart disease, and bladder condition.

The Board remands the claim for service connection for coronary artery disease due to missing private treatment records and the need for a medical opinion on secondary service connection.

The Board denied service connection for heart disease, eye injury, and erectile dysfunction. The Veteran's PTSD with persistent depressive disorder does not warrant a rating in excess of 70 percent, and the prostate cancer does not require a higher rating or additional benefits.

The Veteran's claims of entitlement to service connection for a finger condition, pulmonary valvular stenosis, and hypertension are dismissed due to a procedural defect in the filing of the appeal under the Appeals Modernization Act.

The Board granted service connection for atherosclerosis and hypertension, both presumed to be related to exposure to herbicide agents during active service. The claim for diabetes mellitus was remanded for further development.

The appeal was dismissed due to the Veteran's death while it was pending before the Board of Veterans' Appeals.

The Board denied service connection for various conditions, including Parkinson's disease and related secondary conditions, as the evidence did not support a causal relationship between these conditions and the Veteran's military service or toxic exposure risk activity.

The Board granted service connection for prostate cancer residuals, Parkinson's disease, ischemic heart disease, hypothyroidism, peripheral neuropathy, and testicular disability on a basis other than the PACT Act.

The Board remands the claims for service connection for chronic lymphocytic leukemia (CLL), hypertension, heart condition, and peripheral vascular disease of both lower extremities to obtain additional evidence.

The Board granted service connection for a heart condition, diagnosed as bradycardia, finding that it was proximately caused by the Veteran's service-connected hypertension.

The Board denied the veteran's claims for service connection for various conditions, finding no new and relevant evidence to support a change in previous denials.

The Board denied the Veteran's claim for service connection for a heart disability, to include stable angina and irregular heartbeat, as there was no evidence that the condition began during active service or is otherwise related to an in-service injury or disease.

The Board granted service connection for migraine headaches and a heart condition, diagnosed as sinus tachycardia, and an effective date of September 27, 2022, for the award of service connection for chronic bronchitis with pulmonary hypertension and pulmonary embolism. The Veteran was also awarded special monthly compensation (SMC) based on the need for aid and attendance.

The Board granted an effective date of February 16, 2001, but no earlier, for the award of service connection for diabetes mellitus, type II, and denied an effective date prior to June 22, 2000, for the award of service connection for coronary artery disease (CAD).

The Board denied service connection for heart disease as the evidence did not support a relationship to service.

The Board granted a 30 percent disability evaluation for sinusitis but denied compensable evaluations for allergic rhinitis and coronary artery disease, and remanded the claim for service connection for gastroesophageal reflux disease.

The Board remands the claims for service connection for obesity, anemia, diabetes mellitus (type II), heart disease, hypertension, and sleep apnea as they require further development of evidence.

The Board denied the claims for earlier effective dates for service connection for Parkinson's Disease and Coronary Artery Disease, as the earliest possible effective date under Nehmer regulations is July 30, 2001, and October 28, 2005, respectively.